This article provides a detailed comparison between multiplexed CRISPR interference (CRISPRi) and single-gene repression for researchers and drug development professionals.
This article provides a comprehensive comparison of CRISPR interference (CRISPRi) systems based on catalytically dead Cas9 (dCas9) and Cpf1 (dCpf1) for metabolic engineering.
This article provides a comprehensive framework for researchers and drug development professionals on the integrated use of CRISPRi and Tn-seq to define and validate essential genes.
This article provides a comprehensive comparison of CRISPR interference (CRISPRi) and RNA interference (RNAi) for gene knockdown, tailored for researchers and drug development professionals.
This article provides a comprehensive comparison of two cornerstone technologies in bacterial functional genomics: CRISPR interference (CRISPRi) and transposon sequencing (Tn-seq).
This article provides a comprehensive guide for researchers and drug development professionals on optimizing inducer concentration for partial gene or protein knockdown.
CRISPR interference (CRISPRi) has emerged as a powerful tool for programmable gene repression in bacteria, but its application in GC-rich species presents unique challenges, including inefficient guide RNA binding and...
This article provides a systematic guide for researchers and drug development professionals facing challenges with inefficient CRISPR interference (CRISPRi).
Precise control over dCas9 activity is paramount for the safety and efficacy of CRISPR-based research and therapeutic applications.
This article provides researchers, scientists, and drug development professionals with a strategic framework for minimizing CRISPR off-target effects, a critical challenge in therapeutic genome editing.